They announced an “increased assessment” of their resources. “Assessment.” What does that even mean? They looked at the dirt and decided there was… more dirt? More potential dirt? It’s just marketing speak. And they expect us to get excited? Honestly, the phrasing is just… sloppy.
During the pandemic, when I was mostly just trying to remember which day it was, Morgan Stanley went on a bit of a shopping spree. Twenty billion dollars, they spent on E*TRADE and Eaton Vance. It struck me as…bold. Like buying a yacht during a hurricane. But it worked. They’re now a top asset and wealth management firm. Which is good for them. I mostly manage my own assets, which mostly consist of a slightly chipped ceramic frog and a growing pile of unopened mail.
Vertex has reaped a good harvest from Alyftrek, Trikafta, and the like – solid work, to be sure. They predict further bounty from Casgevy, a gene-editing therapy for sickle cell and thalassemia. But the true promise lies not just in easing suffering, but in curing it. And that, friend, is where CRISPR Therapeutics holds the seed.
Nebius, a company dedicated to the construction of AI infrastructure—powered, naturally, by Nvidia’s hardware—is scaling with a velocity that would impress even the most ardent devotee of progress. The recent financial reports—a 547% surge in quarterly revenue, 479% year-on-year—are, admittedly, impressive. But one is reminded of a particularly flamboyant tulip bulb; a spectacular bloom, certainly, but lacking the substance to endure. The company remains, as yet, unburdened by the inconvenience of profit, and its capital expenditure is, to put it mildly, substantial.
So, Bybit EU decided to launch these reward programs for USDC and EURC-you know, the stablecoins that are as exciting as a Tuesday night in. Circle issued them, and now Bybit’s all like, “Let’s make Europe great again, one regulated stablecoin at a time.” Because nothing says “financial revolution” like complying with MiCA rules. Savings and steady participation? Sure, because who doesn’t love a good nap in the financial markets?
They picked up 2,012,662 shares. A decent chunk. The valuation, as of December 31st, 2025, matched the average trading price. Which, honestly, is just good housekeeping. It’s the messy bits that worry me. Like, what were they thinking? Or, more accurately, what were they trying to signal?
One wonders, naturally, about the scale of this parting. It appears to be the most substantial single divestiture made by Ms. Freve to date, exceeding both the median and the mean of her previous transactions. A curious detail, though perhaps unremarkable in the grand scheme. The reduction in her direct holdings, from eight thousand, eight hundred and forty-five shares to a mere five hundred and thirty-nine, is more significant. A shrinking estate, one might say, though hardly a ruinous one. It leaves her with a stake representing a fraction – a mere 0.0005 percent – of the company’s total outstanding shares. A modest holding, barely sufficient to command a view from the gallery.
Ten years. That’s the timeframe we’re talking about. Enough time for competitors to catch up, for customers to decide DIY is the way forward, and for valuations to experience a healthy dose of gravity. It’s a long time. A lifetime, almost, in tech years. So, let’s talk about two businesses that I think have a fighting chance of eclipsing Nvidia by 2036. Don’t get me wrong, I’m not saying it’s a sure thing. Investing is rarely a sure thing. It’s more like a carefully calculated gamble with a hefty dose of wishful thinking.
These ETFs, hovering near all-time highs like vultures circling a dying carcass, are a prime example. Momentum is shifting, the easy money is drying up, and suddenly, picking winners isn’t just about jumping on the bandwagon—it’s about cold, hard analysis. About understanding where the bodies are going to pile up. It’s about survival, people. Pure and simple. The stakes? Higher than ever. We’re not talking about pocket change here. This is the future of everything, and it’s all built on these tiny, fragile chips.
Meanwhile, the long-term selling pressure in the crypto ballroom conducts itself with the persistence of a stubborn bowler hat. Since its dash to $2.41 in the first week of January, XRP has shed 41.35% in a brisk forty-five days-enough to make a chap’s moustache droop with sympathy.